tenapanor

FDA Drug Profile

Drug Details

Generic Name
tenapanor
Brand Names
N/A
Application Number
Sponsor
Patheon Pharmaceuticals Inc.
NDC Codes
3
Dosage Forms
TABLET, FILM COATED
Routes
N/A
Active Ingredients
TENAPANOR, TENAPANOR HYDROCHLORIDE

Indications and Usage

1 INDICATIONS AND USAGE IBSRELA is indicated for treatment of irritable bowel syndrome with constipation (IBS-C) in adults. IBSRELA is a sodium/hydrogen exchanger 3 (NHE3) inhibitor indicated for treatment of irritable bowel syndrome with constipation (IBS-C) in adults. ( 1 )